Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Visioneering

Explore full profile

Innovative new company that is dedicated to redefining vision

Alpharetta, United StatesFounded 2004Aviation
Valuation <$5M Last recorded · 2024
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Visioneering and the history behind them.

About Visioneering

Visioneering Technologies Inc., founded in 2008 by Dr. Richard A. Griffin, is a medical device company that designs, manufactures, sells and distributes contact lenses for the North American, European and Asia-Pacific markets.

Dr. Griffin, an optometrist with a background in optical and aerospace engineering, dedicated two decades to developing the company's core optical solutions. This extensive research and development period culminated in the creation of the company's flagship product, the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses.

The company's primary business revolves around the sale of these specialized contact lenses. The NaturalVue® lenses are designed to address two common vision problems: presbyopia (age-related farsightedness) in adults and myopia (nearsightedness) in children. The business model is based on the manufacturing and distribution of these lenses to eye care professionals and consumers. Visioneering Technologies operates in the healthcare sector, specifically within the vision care market, serving both patients and eye care practitioners.

The NaturalVue® Multifocal 1 Day contact lenses feature a unique, patented optical design known as Neurofocus Optics® Technology. This design incorporates a center-distance, extended depth-of-focus system that allows for a wide range of clear vision, from near to far. For myopic children, this design has been shown in studies to be effective in managing the progression of their condition. The lenses are made from a hydrogel material and are designed for daily disposable use, which provides a convenient and hygienic option for patients.

Source: Dealroom company data

At a glance

Founded
2004
Headquarters
Alpharetta, United States
Sector
Aviation

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • ATDC
  • MB Venture Partners
  • Charter Life Sciences
  • Regal Funds Management
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States90.9%
🇬🇧 United Kingdom4.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Visioneering on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Visioneering on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.